>
21 CFR Part 812 is the U.S. federal regulation that addresses investigational device exemptions that allow medical devices to be used in a clinical study prior to obtaining market clearance. Read our free regulatory brief for an overview of the regulation and where it is applicable.
More infoWatch ReplayGet the ebookGet the briefGet the case studyGet the data sheetGet the webinarGet the video